Si mostrano 100 riferimenti a partire da 1 |
Per ulteriori informazioni selezionare i riferimenti di interesse.
Simultaneous determination of plasma catecholamine metabolites (homovanillic acid, 3,4-dihydroxy phenyl acetic acid, 3-methoxy-4-hydroxy-phenylglycol) using liquid chromatography with amperometric detection
JOURNAL OF SEPARATION SCIENCE
Effects of haloperidol and phentolamine on the crustacean cardiac ganglion
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY
Monoamine pharmacology of the lobster cardiac ganglion
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY
The effects of olanzapine on neurocognitive functioning in medication-refractory schizophrenia
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
Agranulocytosis in a schizophrenic child receiving clozapine therapy - clinical picture and therapy. a case report
ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE
Simultaneous determination of olanzapine, clozapine and demethylated metabolites in serum by on-line column-switching high-performance liquid chromatography
JOURNAL OF CHROMATOGRAPHY B
Determination of clozapine and its N-desmethyl metabolite by high-performance liquid chromatography with ultraviolet detection
JOURNAL OF CHROMATOGRAPHY B
Discharge prescribing practices: Comparing a research ward to general treatment wards
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
Clozapine-induced concordant agranulocytosis in monozygotic twins
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia
MOLECULAR PSYCHIATRY
Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia
MOLECULAR PSYCHIATRY
Variability in the 5-MT2A receptor gene is associated with seasonal pattern in major depression
MOLECULAR PSYCHIATRY
Association between-G308A tumor necrosis factor alpha gene polymorphism and schizophrenia
MOLECULAR PSYCHIATRY
Asymmetrical hand force persistence and neuroleptic treatment in schizophrenia
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
A double-blind placebo-controlled case study of the use of donepezil to improve cognition in a schizoaffective disorder patient: Functional MRI correlates
NEUROCASE
Anxiety symptoms in schizophrenia: the need for heightened clinician awareness
PRIMARY CARE PSYCHIATRY
Efficacy and safety of clozapine and olanzapine: an open-label study comparing two groups of Parkinson's disease patients with dopaminergic-induced psychosis
PARKINSONISM & RELATED DISORDERS
Management of psychosis in Parkinson's disease
CURRENT OPINION IN NEUROLOGY
How do the atypical antipsychotics work?
JOURNAL OF PSYCHIATRY & NEUROSCIENCE
Long-term treatment with dozapine in an adult with autistic disorder accompanied by aggressive behaviour
JOURNAL OF PSYCHIATRY & NEUROSCIENCE
Influence of novel and conventional antipsychotic medication on subjectivequality of life
JOURNAL OF PSYCHIATRY & NEUROSCIENCE
Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol
JOURNAL OF PSYCHIATRY & NEUROSCIENCE
Quetiapine and obsessive-compulsive symptoms (OCS): case report and reviewof atypical antipsychotic-induced OCS
JOURNAL OF PSYCHIATRY & NEUROSCIENCE
Choosing the right dose of antipsychotics in schizophrenia - Lessons from neuroimaging studies
CNS DRUGS
Bodyweight gain associated with atypical antipsychotics - Epidemiology andtherapeutic implications
CNS DRUGS
Neurotransmitter receptor variants and their influence on antipsychotic treatment (Review)
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
Effectiveness of ECT combined with risperidone against aggression in schizophrenia
JOURNAL OF ECT
Antipsychotic prescribing patterns in the texas prison system
JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW
Commentary: Antipsychotic prescribing practices in the Texas prison system
JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW
Diagnosis and treatment of mood disorders that co-occur with schizophrenia
PSYCHIATRIC SERVICES
Evidence-based pharmacologic treatment for people with severe mental illness: A focus on guidelines and algorithms
PSYCHIATRIC SERVICES
Six-month outcomes for patients who switched to olanzapine treatment
PSYCHIATRIC SERVICES
Rehab rounds - Electroconvulsive therapy in rehabilitation: The Hong Kong experience
PSYCHIATRIC SERVICES
The case of Sam: Multidisciplinary perspectives
PSYCHIATRIC SERVICES
Short-term inpatient pharmacotherapy of schizophrenia
HARVARD REVIEW OF PSYCHIATRY
Neuroleptic treatment of late-life schizophrenia
HARVARD REVIEW OF PSYCHIATRY
First-episode psychosis: Critical management issues during the first two years
HARVARD REVIEW OF PSYCHIATRY
Unanticipated plasma concentrations in two clozapine-treated patients
ANNALS OF PHARMACOTHERAPY
Sudden cardiac death with clozapine and sertraline combination
ANNALS OF PHARMACOTHERAPY
Failure of tolterodine to treat clozapine-induced nocturnal enuresis
ANNALS OF PHARMACOTHERAPY
Neuroleptic malignant syndrome with antidepressant/antipsychotic drug combination
ANNALS OF PHARMACOTHERAPY
Zolpidem for antipsychatic-induced parkinsonism
ANNALS OF PHARMACOTHERAPY
Converting patients from brand-name clozapine to generic clozapine
ANNALS OF PHARMACOTHERAPY
Possible serotonin syndrome associated with clomipramine after withdrawal of clozapine
ANNALS OF PHARMACOTHERAPY
Euglycemic clamp study in clozapine-induced diabetic ketoacidosis
ANNALS OF PHARMACOTHERAPY
Safety and efficacy of risperidone in substance abusers with psychosis
AMERICAN JOURNAL ON ADDICTIONS
Storage, recall, and novelty detection of sequences by the hippocampus: Elaborating on the SOCRATIC model to account for normal and aberrant effects of dopamine
HIPPOCAMPUS
Atypical neuroleptic drugs downregulate dopamine sensitivity in rat cortical and striatal astrocytes
MOLECULAR AND CELLULAR NEUROSCIENCE
Zuclopenthixol treatment of behavioral disturbances in mentally retarded children and adolescents: An open-label study
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
Hyperglycemia and hypertriglyceridemia secondary to olanzapine
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
Quetiapine treatment of children with Tourette's syndrome: Report of two cases
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
New subscales for an anchored version of the Brief Psychiatric Rating Scale: Construction, reliability, and validity in acute psychiatric admissions
PSYCHOLOGICAL ASSESSMENT
Serotonin type 2a (5-HTR2A) receptor gene polymorphism and personality traits in patients with major psychoses
RUSSIAN JOURNAL OF GENETICS
Modified synthesis of 11-[C-14]-clozapine
APPLIED RADIATION AND ISOTOPES
Structure-activity relationships in 2,2-diphenyl-2-ethylthioacetic acid esters: Unexpected agonistic activity in a series of muscarinic antagonists
BIOORGANIC & MEDICINAL CHEMISTRY
6-(4-benzylpiperazin-1-yl)benzodioxanes as selective ligands at cloned primate dopamine D-4 receptors
BIOORGANIC & MEDICINAL CHEMISTRY
Serum IL-1 beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment
MEDIATORS OF INFLAMMATION
Association between the 5 ' UTR variant C178T of the serotonin receptor gene HTR3A and bipolar affective disorder
PHARMACOGENETICS
Genetic variants of the serotonin system and weight change during clozapine treatment
PHARMACOGENETICS
Further evidence of human leukocyte antigen-encoded susceptibility to clozapine-induced agranulocytosis independent of ancestry
PHARMACOGENETICS
Decreased pallidal GABA following reverse microdialysis with, clozapine, but not haloperidol
NEUROREPORT
Clozapine, but not haloperidol, reverses social behavior deficit in mice during withdrawal from chronic phencyclidine treatment
NEUROREPORT
Phencyclidine (PCP)-induced deficits of prepulse inhibition in monkeys
NEUROREPORT
Common discriminative stimulus properties in rats of muscarinic antagonists, clozapine and the D-3 preferring antagonist PNU-99194A: an analysis of possible mechanisms
BEHAVIOURAL PHARMACOLOGY
Effects of benztropine on ketamine-induced behaviors in Cebus monkeys
BEHAVIOURAL PHARMACOLOGY
Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): possible involvement of calcium and nitric oxide
BEHAVIOURAL PHARMACOLOGY
Acute and chronic neutropenias. What is new?
JOURNAL OF INTERNAL MEDICINE
BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs
EUROPEAN JOURNAL OF NEUROSCIENCE
Electrophysiological characterization of laminar synaptic inputs to the olfactory tubercle of the rat studied in vitro: modulation of glutamatergic transmission by cholinergic agents is pathway-specific
EUROPEAN JOURNAL OF NEUROSCIENCE
Fibroblast growth factor-2 is selectively modulated in the rat brain by E-5842, a preferential sigma-1 receptor ligand and putative atypical antipsychotic
EUROPEAN JOURNAL OF NEUROSCIENCE
Treatment of the mentally disordered offender
CURRENT OPINION IN PSYCHIATRY
The genetics of schizophrenia
CURRENT OPINION IN PSYCHIATRY
Comorbid conditions in schizophrenia
CURRENT OPINION IN PSYCHIATRY
Antipsychotic drug treatment: recent advances
CURRENT OPINION IN PSYCHIATRY
Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint [I-123]IBZM SPECT study
PSYCHIATRY RESEARCH-NEUROIMAGING
Different effects of antipsychotic drugs on insulin release in vitro
EUROPEAN NEUROPSYCHOPHARMACOLOGY
D-2 and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study
EUROPEAN NEUROPSYCHOPHARMACOLOGY
Different fatal toxicity of neuroleptics identified by autopsy
EUROPEAN NEUROPSYCHOPHARMACOLOGY
New onset diabetes and atypical antipsychotics
EUROPEAN NEUROPSYCHOPHARMACOLOGY
Good tolerability equals good results: the patient's perspective
EUROPEAN NEUROPSYCHOPHARMACOLOGY
The health economic implications of treatment with quetiapine: an audit oflong-term treatment for patients with chronic schizophrenia
EUROPEAN PSYCHIATRY
Long-term treatment of chronic schizophrenia with risperidone: a study with plasma levels
EUROPEAN PSYCHIATRY
Quality of life in schizophrenia: contributions of anxiety and depression
SCHIZOPHRENIA RESEARCH
Neuroleptics normalize increased release of interleukin-1 beta and tumor necrosis factor-alpha from monocytes in schizophrenia
SCHIZOPHRENIA RESEARCH
Quantitative EEG in schizophrenia and in response to acute and chronic clozapine treatment
SCHIZOPHRENIA RESEARCH
Weight gain over 4 months in schizophrenia patients: a comparison of olanzapine and risperidone
SCHIZOPHRENIA RESEARCH
Association analysis of polymorphism in the promoter region of the alpha 2a-adrenoceptor gene with schizophrenia and clozapine response
SCHIZOPHRENIA RESEARCH
Corpus callosum and P300 in schizophrenia
SCHIZOPHRENIA RESEARCH
The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance
SCHIZOPHRENIA RESEARCH
Prefrontal cortical sulcal widening associated with poor treatment response to clozapine
SCHIZOPHRENIA RESEARCH
Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study
SCHIZOPHRENIA RESEARCH
Neuropsychological change in schizophrenia after 6 weeks of clozapine
SCHIZOPHRENIA RESEARCH
Reduction of tardive dyskinesia with quetiapine
SCHIZOPHRENIA RESEARCH
Lack of association between the T -> C 267 serotonin 5-MT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia
SCHIZOPHRENIA RESEARCH
Psychopharmacology in pregnancy
JOURNAL OF PERINATAL & NEONATAL NURSING
Dopamine D-2 receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects
NEUROPSYCHOPHARMACOLOGY
Computerized neurocognitive scanning: II. The profile of schizophrenia
NEUROPSYCHOPHARMACOLOGY
The effect of olanzapine treatment on monoamine metabolite concentrations in the cerebrospinal fluid of schizophrenic patients
NEUROPSYCHOPHARMACOLOGY
Inverse agonist properties of antipsychotic agents at cloned, human (h) serotonin (5-HT)(1B) and h5-HT1D receptors
NEUROPSYCHOPHARMACOLOGY